Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae

被引:8
|
作者
Seok, Hyeri [1 ]
Kang, Cheol-In [1 ]
Huh, Kyungmin [1 ]
Cho, Sun Young [1 ]
Ha, Young Eun [1 ]
Chung, Doo Ryeon [1 ]
Peck, Kyong Ran [1 ]
机构
[1] Sungkyunkwan Univ, Div Infect Dis, Dept Med, Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06531, South Korea
关键词
S; pneumoniae; levofloxacin-nonsusceptible; community-onset pneumonia; risk factor; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; INFECTION; SUSCEPTIBILITIES; PREVALENCE; PATHOGENS; CHILDREN;
D O I
10.1089/mdr.2017.0416
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Fluoroquinolones are antibiotics commonly used in the treatment of infections caused by Streptococcus pneumoniae. However, rates of fluoroquinolone resistance are increasing with their frequent use. We designed this study to verify current fluoroquinolone resistance rates and risk factors for community-onset pneumococcal pneumonia. Methods: A retrospective case-control study was conducted in a tertiary referral hospital. The study population comprised patients admitted for pneumococcal pneumonia between January 2011 and May 2017. The case group included community-onset pneumonia caused by levofloxacin-nonsusceptible S. pneumoniae. The control group consisted of two patients with levofloxacin-susceptible S. pneumoniae who were admitted around the same time as each case. Results: A total of 198 pneumococcal pneumonia cases were identified during the study period. Twenty-five levofloxacin-resistant S. pneumoniae cases and 3 levofloxacin-intermediate S. pneumoniae cases were included in the case group (nonsusceptibility rate=14.1%). Multivariate analysis showed that healthcare-associated factors (odds ratio [OR] 4.78, 95% confidence interval [CI] 1.39-16.43, p=0.013), bronchopulmonary disease (OR 3.79, 95% CI 1.07-13.40, p=0.039), cerebrovascular disease (OR 6.08, 95% CI 1.24-29.75, p=0.026), and exposure to fluoroquinolones within the previous 3 months (OR 5.89, 95% CI 1.21-28.68, p=0.028) were associated with nonsusceptibility to levofloxacin. Conclusion: Independent risk factors for levofloxacin-nonsusceptible pneumococcal pneumonia were recent hospitalization, bronchopulmonary disease, cerebrovascular disease, and prior antibiotic use within 3 months. Careful selection of empirical antibiotics is thus needed in at-risk patients. Similarly, efforts to prevent the interpersonal spread of drug-resistant pathogens in long-term care facilities and to restrict unnecessary fluoroquinolone prescriptions are important.
引用
收藏
页码:1412 / 1416
页数:5
相关论文
共 50 条
  • [1] Risk factors for community-onset pneumococcal pneumonia caused by levofloxacin non-susceptible Streptococcus pneumoniae
    Seok, H.
    Kang, C-I
    Hyun, M.
    Lim, K. R.
    Shi, H.
    Huh, K.
    Cho, S. Y.
    Ha, Y. E.
    Chung, D. R.
    Peck, K. R.
    Song, J-H
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S159 - S159
  • [2] Risk factors for levofloxacin-nonsusceptible Streptococcus pneumoniae in community-acquired pneumococcal pneumonia: a nested case–control study
    C.-I. Kang
    J.-H. Song
    S. H. Kim
    D. R. Chung
    K. R. Peck
    T. M. So
    P.-R. Hsueh
    European Journal of Clinical Microbiology & Infectious Diseases, 2014, 33 : 55 - 59
  • [3] Risk factors for levofloxacin-nonsusceptible Streptococcus pneumoniae in community-acquired pneumococcal pneumonia: a nested case-control study
    Kang, C. -I.
    Song, J. -H.
    Kim, S. H.
    Chung, D. R.
    Peck, K. R.
    So, T. M.
    Hsueh, P. -R.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (01) : 55 - 59
  • [4] High prevalence of multiresistance in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea
    Lee, Sungkyoung
    Kim, Seong-Han
    Park, Misun
    Bae, Songmee
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (02) : 227 - 231
  • [5] Therapeutic options among broad-spectrum β-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae
    Jones, RN
    Fritsche, TR
    Sader, HS
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (02) : 129 - 133
  • [6] Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America
    Johnson, CN
    Benjamin, WH
    Moser, SA
    Hollingshead, SK
    Zheng, XT
    Crain, MJ
    Nahm, MH
    Waites, KB
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (06) : 2458 - 2464
  • [7] Emergence of multidrug-resistant clones in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea
    Baek, Jin Yang
    Kang, Cheol-In
    Kim, So Hyun
    Ko, Kwan Soo
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Lee, Nam Yong
    Song, Jae-Hoon
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (03) : 287 - 290
  • [8] Pneumonia caused by penicillin-nonsusceptible Streptococcus pneumoniae:: Clinical characteristics, prognostic factors, and outcomes
    Wu, TT
    Hsueh, PR
    Lee, LN
    Yang, PC
    Luh, KT
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2000, 99 (01) : 18 - 23
  • [9] Community-onset bacteraemia caused by fluoroquinolone-resistant Klebsiella pneumoniae: clinical epidemiology and risk factors
    Kang, Cheol-In
    Lee, Jeong-A
    Wi, Yu Mi
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Lee, Nam Yong
    Song, Jae-Hoon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (02) : 181 - 182
  • [10] Risk factors for community-onset pneumonia caused by drug-resistant pathogens: A prospective cohort study
    Vasco Barreto, J.
    Dias, Claudia Camila
    Cardoso, Teresa
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 96 : 66 - 73